Industry News

Mirvaso Approved for the Treatment of Rosacea-Related Facial Erythema

Mirvaso Approved for the Treatment of Rosacea-Related Facial Erythema

Physicians and patients now have a new tool available to combat the diffuse redness and flushing of rosacea. The United States Food and Drug Administration (FDA) has approved Galderma’s Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of rosacea-related facial erythema in adults 18 years of age or older. The once-daily gel acts quickly to reduce the redness of rosacea and lasts up to 12 hours, according to clinical data. The company expects the gel to be available in pharmacies in September 2013.

AbobotulinumtoxinA may offer faster onset of action and longer duration of results

A split-face study comparing the onset of action, change in degree of wrinkles, patient satisfaction, duration of effect and adverse effects of OnabotulinumtoxinA (ONA; Botox, Allergan, and AbobotulinumtoxinA (ABO; Dysport, Valeant Pharmaceuticals) has revealed subtle differences between the two popular injectables. Ramtin Kassir, MD, et al, treated 85 patients aged 18-75 with moderate to severe wrinkles in either the glabellar or crow’s feet area, or both. Patients who had conditions that would interefere with the assessment of wrinkles were excluded.

AAD Releases Statement on Oral Supplements for Sun Protection

Recent discussion in the media about sun protection supplements has prompted an official statement from the American Academy of Dermatology (AAD). The statement, issued on August 22 by Dirk M. Elston, MD, FAAD, president of the AAD, reads:

The American Academy of Dermatology wants to alert consumers that these pills should not be used as a replacement for sunscreen or sun-protective clothing. There is currently no scientific evidence that oral supplements alone can provide an adequate level of protection from the sun’s damaging ultraviolet rays.

Merz Acquires NEOCUTIS

Merz Pharma Group (www.merz.com) has acquired Neocutis S.A.’s privately held cosmetics, OTC and Rx skincare business. The acquisition, which closed on July 22, 2013, will be managed in North America by Merz Pharma Group’s U.S. affiliate, Merz North America, which will also integrate marketing of Neocutis’ line of physician-dispensed topical skin care products in the U.S.

DermatologistOnCall Launches Mobile Application

Iagnosis, in partnership with Newton Consulting, has launched a mobile platform for its online dermatology care site, www.dermatologistoncall.com. The site offers online access to board-certified dermatologists. Patients create a private and secure account where they can submit photographs and descriptions of their condition and receive a response from a dermatologist within three business days.

YoDerm Launches, Offering Online Dermatology Consults

YoDerm Launches, Offering Online Dermatology Consults

YoDerm (www.yoderm.com) a startup located on California's central coast, is touting itself as the world's first acne-specific dermatology web-platform. The site allows users to upload images and get a physician diagnosis as well as prescriptions for their acne. For $59, website visitors can upload photos of their acne and answer a simple medical questionnaire. Within 48 hours, a YoDerm dermatologist will examine the photos and information and create a personalized treatment plan based on the patient’s skin type and acne severity.

Kareo Acquires ECCO Health

Kareo, a provider of cloud-based medical office software and services for small medical practices, has acquired privately held ECCO Health, a full-service provider of medical billing and associated solutions. Kareo has extended employment offers to all ECCO managers and employees and all are expected to join the new combined company.

In Memoriam

Main Image: 
James Edwin Fulton, MD

The world of clinical skin care lost two of its innovators and pioneers this month. Dermatologist and founder of Vivant Skin Care James Edwin Fulton, Jr., MD, died last week. He was 73. Surrounded by his wife of 44 years, Vivant Skin Care President Sara M. Fulton, daughter and CEO Kelly Fulton-Kendrick, daughter Susan Fulton-Arregui, son James Edwin Fulton, III and son George Jacob Fulton, Fulton succumbed to colon cancer at Mercy Hospital in Miami.

Articles: